Population Health

The aim is to use the technology to track daily patient data and “plan interventional strategies in real-time to avoid complications of the disease,” according to findings from the Future Economy Lab workshop.

Software company Genpact UK has been paid £1.5m for an AI tool that will be used to process the adverse reactions of the COVID-19 vaccines.  

HealthTree founder Jenny Ahlstrom, who was diagnosed with multiple myeloma a decade ago, said policy changes that have facilitated access to virtual care should remain permanent.

The COVID-19 crisis has led to major leaps forward for telehealth, decision support and more, says Hal Wolf – but big work remains on interoperability, patient ID, social determinants and other building blocks of population health.  

Clinical decision support and hospital resource-management are particularly important as patient numbers begin to increase again, two new JAMA studies show.

The artificial kidneys can be wearable, implanted, bioengineered, developed as a xenotransplant or chimera organ, or created using a different approach.

Bart De Witte, founder of the HIPPO AI Foundation, says COVID-19 has encouraged stakeholders to collaborate more effectively on the use of data, which he hopes will help reduce health inequalities in a post-coronavirus world.

A report from the U.S. Centers for Disease Control and Prevention found that about 1.6 million telehealth encounters occurred via four major vendors from January through March.

Global health leaders debated over the role and potential contribution of technologies in dealing with the COVID-19 outbreak during a panel discussion entitled: ‘How can digital tools help tackle a pandemic?’ at the Barcelona Health Summit, which was held last week (29 October 2020).

Ian Slade, chair of the HIMSS Chapter Advocacy Taskforce, says there's a huge disparity in health literacy, which affects how people navigate the labyrinth of healthcare.